Prognostic Impact of Coagulation Activity in Patients Undergoing Curative Resection for Pancreatic Ductal Adenocarcinoma

被引:6
|
作者
Matsumura, Kazuki [1 ]
Hayashi, Hiromitsu [1 ]
Uemura, Norio [1 ]
Zhao, Liu [1 ]
Higashi, Takaaki [1 ]
Yamao, Takanobu [1 ]
Kitamura, Fumimasa [1 ]
Nakao, Yusuke [1 ]
Yusa, Toshihiko [1 ]
Itoyama, Rumi [1 ]
Imai, Katsunori [1 ]
Yamashita, Yo-Ichi [1 ]
Baba, Hideo [1 ]
机构
[1] Kumamoto Univ, Grad Sch Life Sci, Dept Gastroenterol Surg, Kumamoto, Japan
来源
IN VIVO | 2020年 / 34卷 / 05期
关键词
Pancreatic ductal adenocarcinoma; coagulation activity; coagulation disorders; PT-INR; prognosis; TISSUE FACTOR; HEPATOID CARCINOMA; FACTOR VIIA; CANCER; METASTASIS; ACTIVATION; SURVIVAL; LUNG;
D O I
10.21873/invivo.12111
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: The aim of this study was to elucidate the clinical impact of coagulation disorders on outcomes after curative resection of pancreatic ductal adenocarcinoma. Patients and Methods: Preoperative coagulation activity in 135 patients, who had undergone curative resections for pancreatic ductal adenocarcinoma was retrospectively evaluated and the impact on survival outcomes analyzed. Results: A prolonged prothrombin time-international normalized ratio (PT-INR) (>= 1.1) was detected in 23/135 patients (17%). Univariate analysis that showed prolonged PT-INR was associated with worse relapse-free (hazard ratio.1 .79, p=0.044) and overall (hazard ratio=2.18, p=0.004) survival. Multivariate analyses showed prolonged PT-INR, large tumor (>30 mm), and lymph node metastasis were independent predictors of poor overall survival. Conclusion: Prolonged PT-INR may be a predictor of poor prognosis in patients with pancreatic ductal adenocarcinoma who have undergone curative resection. Coagulation disorders may be a therapeutic target for improving outcomes of pancreatic ductal adenocarcinoma.
引用
收藏
页码:2845 / 2850
页数:6
相关论文
共 50 条
  • [1] Prognostic impact of osteosarcopenia in patients undergoing pancreatic resection for pancreatic ductal adenocarcinoma
    Yanagaki, Mitsuru
    Onda, Shinji
    Gocho, Takeshi
    Igarashi, Yosuke
    Shirai, Yoshihiro
    Okui, Norimitsu
    Matsumoto, Michinori
    Sakamoto, Taro
    Haruki, Koichiro
    Ikegami, Toru
    LANGENBECKS ARCHIVES OF SURGERY, 2024, 409 (01)
  • [2] Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Resection
    Toshiya Abe
    Kohei Nakata
    So Nakamura
    Noboru Ideno
    Naoki Ikenaga
    Nobuhiro Fujita
    Kousei Ishigami
    Kazuyoshi Nishihara
    Masafumi Nakamura
    Annals of Surgical Oncology, 2023, 30 : 6673 - 6679
  • [3] Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Resection
    Abe, Toshiya
    Nakata, Kohei
    Nakamura, So
    Ideno, Noboru
    Ikenaga, Naoki
    Fujita, Nobuhiro
    Ishigami, Kousei
    Nishihara, Kazuyoshi
    Nakamura, Masafumi
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (11) : 6673 - 6679
  • [4] Statins potentially improve survival of patients undergoing curative resection for pancreatic ductal adenocarcinoma
    Petermann, D.
    Kefleyesus, A.
    Demartines, N.
    Schaefer, M.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 6 - 7
  • [5] Prognostic Factors in Patients With Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Resection
    Ren, Weizheng
    Xourafas, Dimitrios
    Ashley, Stanley W.
    Clancy, Thomas E.
    AMERICAN SURGEON, 2022, 88 (06) : 1172 - 1180
  • [6] IMPACT OF POSTOPERATIVE PANCREATIC FISTULA ON THE PROGNOSIS OF PATIENTS UNDERGOING RESECTION FOR PANCREATIC DUCTAL ADENOCARCINOMA
    Sugimoto, Motokazu
    Kobayashi, Shin
    Takahashi, Shinichiro
    Konishi, Masaru
    Gotohda, Naoto
    GASTROENTEROLOGY, 2019, 156 (06) : S1446 - S1446
  • [7] The impact of SPARC expression in survival of pancreatic ductal adenocarcinoma patients after curative resection
    Murakawa, Masaaki
    Aoyama, Toru
    Miyagi, Yohei
    Atsumi, Yousuke
    Kazama, Keisuke
    Kobayashi, Satoshi
    Ueno, Makoto
    Morimoto, Manabu
    Yamamoto, Naoto
    Sato, Tsutomu
    Yoshikawa, Takaki
    Rino, Yasushi
    Masuda, Munetaka
    Morinaga, Soichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [8] The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection
    Murakawa, Masaaki
    Aoyama, Toru
    Miyagi, Yohei
    Kobayashi, Satoshi
    Ueno, Makoto
    Morimoto, Manabu
    Numata, Masakatsu
    Yamamoto, Naoto
    Tamagawa, Hiroshi
    Yukawa, Norio
    Rino, Yasushi
    Masuda, Munetaka
    Morinaga, Soichiro
    JOURNAL OF CANCER, 2019, 10 (03): : 627 - 633
  • [9] The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection
    Elisabeth S. Gruber
    Gerd Jomrich
    Alexandra Kaider
    Michael Gnant
    Klaus Sahora
    Martin Schindl
    Annals of Surgical Oncology, 2020, 27 : 2017 - 2024
  • [10] The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection
    Gruber, Elisabeth S.
    Jomrich, Gerd
    Kaider, Alexandra
    Gnant, Michael
    Sahora, Klaus
    Schindl, Martin
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (06) : 2017 - 2024